Invitrogen will commercialize these sequences over the next few years, allowing the company to expand its NCode microRNA microarray product line into the field of non-coding RNA profiling. This expanded content will enable Invitrogen to provide the most comprehensive non-coding RNA product portfolio in the market and be the first company to provide this new content to the research community.
Peter Welch, director of research and development for gene expression profiling at Invitrogen, said: “MicroRNAs have a discrete function in gene regulation, but the larger non-coding RNAs are involved in multiple roles such as cellular aging and protein assembly, in addition to simple gene regulation.”